Risk of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Among Patients with Type 2 Diabetes Mellitus on Anti-Hyperglycemic Medications

Press/Media: Research

PeriodMay 31 2024

Media coverage

1

Media coverage